Drs. Seth Pollack and Robin Jones make the case for an intentional focus on advancing immunotherapy for sarcomas.
Drs. Fletcher and Thomas write about hope, optimism and the scientific limits that impact oncologists and sarcoma patients.
Experimental Plan: Dr. William A. May describes his study of the interaction between EWS/FLI1 and GLI1 in Ewing's sarcoma.
Study Report: Ms. McConechy and Drs. Huntsman, Lee, and Clarke report their findings on the transdifferentiation of uterine carcinoma into sarcoma and the frequent PI3K pathway mutations in uterine carcinosarcoma.
Study Report: Drs. Highfill, Orentas, and Mackall write about their findings on immunotherapy for pediatric sarcomas and their research approach moving forward.
Additions to the Initiative's Medical Advisory and Editorial Board
The Brian Morden Foundation and the Liddy Shriver Sarcoma Initiative are co-funding a grant for Ewing's sarcoma research in Los Angeles.